Sawai Pharmaceutical Co Ltd (4555) - Financial and Strategic SWOT Analysis Review
![](/report_cover/1896/sawai-pharmaceutical-co-ltd-4555-financial-n-strategic-swot-analysis-review_en.gif)
Sawai Pharmaceutical Co Ltd (4555) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Sawai Pharmaceutical Co Ltd (Sawai Pharmaceutical) manufactures, sells, imports and exports ethical drugs and proprietary drugs. The company's products include cardiovascular drugs, antihyperlipidemic agents, diabetes drugs, anticancer drugs and OTC drugs. It provides products in the form of tablets, oral dispersing tablets, capsules, granule, injection, tape, ophthalmic and nasal solution and syrup. Sawai Pharmaceutical caters to hospitals, general practitioners and dispensing pharmacies. The company has manufacturing facilities in Kanto, Osaka, Sanda and Kyusyu. It has its presence in Sapporo, Sendai, Kitakanto, Tokyo Daiichi, Tokyo Daini, Nagoya, Osaka, Hiroshima and Fukuoka. Sawai Pharmaceutical is headquartered in Osaka, Japan.
Sawai Pharmaceutical Co Ltd Key Recent Developments
Jun 18,2020: Sawai launches 14 generic drugs with 29 strengths
Feb 17,2020: Sawai receives approvals for 15 generic drugs with 31 strengths
Jul 23,2019: Sawai selected for FTSE4Good and FTSE Blossom Japan Indexes
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Sawai Pharmaceutical Co Ltd (Sawai Pharmaceutical) manufactures, sells, imports and exports ethical drugs and proprietary drugs. The company's products include cardiovascular drugs, antihyperlipidemic agents, diabetes drugs, anticancer drugs and OTC drugs. It provides products in the form of tablets, oral dispersing tablets, capsules, granule, injection, tape, ophthalmic and nasal solution and syrup. Sawai Pharmaceutical caters to hospitals, general practitioners and dispensing pharmacies. The company has manufacturing facilities in Kanto, Osaka, Sanda and Kyusyu. It has its presence in Sapporo, Sendai, Kitakanto, Tokyo Daiichi, Tokyo Daini, Nagoya, Osaka, Hiroshima and Fukuoka. Sawai Pharmaceutical is headquartered in Osaka, Japan.
Sawai Pharmaceutical Co Ltd Key Recent Developments
Jun 18,2020: Sawai launches 14 generic drugs with 29 strengths
Feb 17,2020: Sawai receives approvals for 15 generic drugs with 31 strengths
Jul 23,2019: Sawai selected for FTSE4Good and FTSE Blossom Japan Indexes
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Sawai Pharmaceutical Co Ltd - Key Facts
Sawai Pharmaceutical Co Ltd - Key Employees
Sawai Pharmaceutical Co Ltd - Key Employee Biographies
Sawai Pharmaceutical Co Ltd - Major Products and Services
Sawai Pharmaceutical Co Ltd - History
Sawai Pharmaceutical Co Ltd - Company Statement
Sawai Pharmaceutical Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Sawai Pharmaceutical Co Ltd - Business Description
Geographical Segment: Japan
Performance
Geographical Segment: The US
Performance
Sawai Pharmaceutical Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Sawai Pharmaceutical Co Ltd - Strengths
Sawai Pharmaceutical Co Ltd - Weaknesses
Sawai Pharmaceutical Co Ltd - Opportunities
Sawai Pharmaceutical Co Ltd - Threats
Sawai Pharmaceutical Co Ltd - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Sawai Pharmaceutical Co Ltd, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jun 18, 2020: Sawai launches 14 generic drugs with 29 strengths
Feb 17, 2020: Sawai receives approvals for 15 generic drugs with 31 strengths
Jul 23, 2019: Sawai selected for FTSE4Good and FTSE Blossom Japan Indexes
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Sawai Pharmaceutical Co Ltd - Key Facts
Sawai Pharmaceutical Co Ltd - Key Employees
Sawai Pharmaceutical Co Ltd - Key Employee Biographies
Sawai Pharmaceutical Co Ltd - Major Products and Services
Sawai Pharmaceutical Co Ltd - History
Sawai Pharmaceutical Co Ltd - Company Statement
Sawai Pharmaceutical Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Sawai Pharmaceutical Co Ltd - Business Description
Geographical Segment: Japan
Performance
Geographical Segment: The US
Performance
Sawai Pharmaceutical Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Sawai Pharmaceutical Co Ltd - Strengths
Sawai Pharmaceutical Co Ltd - Weaknesses
Sawai Pharmaceutical Co Ltd - Opportunities
Sawai Pharmaceutical Co Ltd - Threats
Sawai Pharmaceutical Co Ltd - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Sawai Pharmaceutical Co Ltd, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jun 18, 2020: Sawai launches 14 generic drugs with 29 strengths
Feb 17, 2020: Sawai receives approvals for 15 generic drugs with 31 strengths
Jul 23, 2019: Sawai selected for FTSE4Good and FTSE Blossom Japan Indexes
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Sawai Pharmaceutical Co Ltd, Key Facts
Sawai Pharmaceutical Co Ltd, Key Employees
Sawai Pharmaceutical Co Ltd, Key Employee Biographies
Sawai Pharmaceutical Co Ltd, Major Products and Services
Sawai Pharmaceutical Co Ltd, History
Sawai Pharmaceutical Co Ltd, Subsidiaries
Sawai Pharmaceutical Co Ltd, Key Competitors
Sawai Pharmaceutical Co Ltd, Ratios based on current share price
Sawai Pharmaceutical Co Ltd, Annual Ratios
Sawai Pharmaceutical Co Ltd, Annual Ratios (Cont...1)
Sawai Pharmaceutical Co Ltd, Annual Ratios (Cont...2)
Sawai Pharmaceutical Co Ltd, Interim Ratios
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Sawai Pharmaceutical Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Sawai Pharmaceutical Co Ltd, Key Facts
Sawai Pharmaceutical Co Ltd, Key Employees
Sawai Pharmaceutical Co Ltd, Key Employee Biographies
Sawai Pharmaceutical Co Ltd, Major Products and Services
Sawai Pharmaceutical Co Ltd, History
Sawai Pharmaceutical Co Ltd, Subsidiaries
Sawai Pharmaceutical Co Ltd, Key Competitors
Sawai Pharmaceutical Co Ltd, Ratios based on current share price
Sawai Pharmaceutical Co Ltd, Annual Ratios
Sawai Pharmaceutical Co Ltd, Annual Ratios (Cont...1)
Sawai Pharmaceutical Co Ltd, Annual Ratios (Cont...2)
Sawai Pharmaceutical Co Ltd, Interim Ratios
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Sawai Pharmaceutical Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Sawai Pharmaceutical Co Ltd, Performance Chart (2016 - 2020)
Sawai Pharmaceutical Co Ltd, Ratio Charts
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
COMPANIES MENTIONED
Sumitomo Dainippon Pharma Co Ltd
Sosei Co Ltd
COSMOS Pharmaceutical Corporation
Chugai Pharmaceutical Co Ltd
ASKA Pharmaceutical Co Ltd
Sawai Pharmaceutical Co Ltd, Performance Chart (2016 - 2020)
Sawai Pharmaceutical Co Ltd, Ratio Charts
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
COMPANIES MENTIONED
Sumitomo Dainippon Pharma Co Ltd
Sosei Co Ltd
COSMOS Pharmaceutical Corporation
Chugai Pharmaceutical Co Ltd
ASKA Pharmaceutical Co Ltd